CDR-348T

N/A

Report date: 2022/05/10 11:43:46
NME

Base Information

Drug NameCDR-348T
Drug Alias NameCDR348T
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionRNA modulatorsMicroRNAs modulators
TargetsMicroRNAsRibonucleic Acid
Therapy Area/IndicationsCardiomyopathy, Hypertrophic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHannover Medical School
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Hypertrophic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A